Copyright
©2009 The WJG Press and Baishideng.
World J Gastroenterol. Oct 28, 2009; 15(40): 5058-5066
Published online Oct 28, 2009. doi: 10.3748/wjg.15.5058
Published online Oct 28, 2009. doi: 10.3748/wjg.15.5058
Table 2 Genotype distribution with regard to treatment n (%)
| UGT1A1 status | FOLFIRI | IROX | All |
| WT (6/6) | 19 (34.5) | 22 (44.0) | 41 (39.0) |
| (6/7) | 28 (50.9) | 24 (48.0) | 52 (49.5) |
| (7/7) | 7 (12.7) | 3 (6.0) | 10 (9.5) |
| (5/7) | 1 (1.8) | 1 (2.0) | 2 (1.9) |
-
Citation: Schulz C, Heinemann V, Schalhorn A, Moosmann N, Zwingers T, Boeck S, Giessen C, Stemmler HJ.
UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer. World J Gastroenterol 2009; 15(40): 5058-5066 - URL: https://www.wjgnet.com/1007-9327/full/v15/i40/5058.htm
- DOI: https://dx.doi.org/10.3748/wjg.15.5058